Fundz

VisiRose raised $3M in Seed financing to support new initiatives in developing treatments for serious eye infections.

PRIVATEJan 16, 2025

Amount Raised

$3 Million

Round Type

Seed

KnoxvilleBiotechnologyHealth CareTherapeutics

Description

VisiRose, a Knoxville-based clinical-stage biotechnology company, raised $3M in Seed funding. The funds will be used to support drug submissions and to initiate clinical trials for their investigational treatments.

Quick answer

VisiRose raised $3 Million in a Seed round, dated January 16, 2025. VisiRose is based in Knoxville, Tennessee, United States.

How much did VisiRose raise?
VisiRose raised $3 Million in a Seed round on January 16, 2025.
What does VisiRose do?
VisiRose is a clinical-stage biotechnology company based in Knoxville, TN.
Where is VisiRose based and how big is it?
VisiRose is based in Knoxville, Tennessee, United States. Fundz records about 4 employees.
Who are the decision-makers at VisiRose?
Fundz holds 1 contact at VisiRose. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as VisiRose that raised within 45 days of this round, from Fundz verified event records.

  • Eikon Therapeutics raised $351M (Series D) on February 26, 2025.
  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
  • Solid IO raised $839K (Seed) on February 24, 2025.
  • Humane Genomics raised an undisclosed amount (Seed) on February 21, 2025.
  • Ceretas raised $1M (Seed) on February 21, 2025.
  • Reverb Therapeutics raised $12M (Seed) on February 19, 2025.

Who to call at VisiRose, and when

A new round usually means VisiRose is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VisiRose raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VisiRose, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VisiRose. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VisiRose

Location

Knoxville, Tennessee, United States

About

VisiRose is a clinical-stage biotechnology company based in Knoxville, TN. It focuses on developing innovative treatments for serious eye infections and conditions through non-invasive therapies. The company is leveraging research from notable institutions and collaborates with Provectus Biopharmaceuticals to advance its therapeutic platform. VisiRose aims to enhance patient outcomes in ocular health using its unique investigational drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VisiRose raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for VisiRose's next move

See what Strategic adds

VisiRose raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.